EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells
- PMID: 18271016
- DOI: 10.1002/jor.20597
EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells
Abstract
Ewing's Family Tumors (EFTs) most commonly harbor a specific t(11;22) translocation that generates the EWS/FLI1 fusion protein responsible for malignant transformation. Many potential downstream targets of EWS/FLI1 have been identified but a detailed mechanism by which the fusion protein brings about transformation remains unknown. In this report, we show that depletion of EWS/FLI1 in Ewing's cell lines results in a senescence phenotype, a marked increase in expression of the G1/S regulatory proteins p27(kip1) and p57(kip2), and a significant decrease in cyclin D1 and CDK2. We also demonstrate for the first time, to our knowledge, that knockdown of EWS/FLI1 leads to hypophosphorylation and functional activation of the retinoblastoma (pRb) family of proteins. Consistent with activation of the pRb proteins, E2F-responsive genes such as cyclin A are repressed in EWS/FLI1-depleted cells. Together, these results support the role of EWS/LI1 as an inhibitor of cellular senescence and implicate the retinoblastoma family of proteins as key mediators of this inhibition.
(c) 2008 Orthopaedic Research Society.
Similar articles
-
The possible role of EWS-Fli1 in evasion of senescence in Ewing family tumors.Cancer Res. 2006 Jan 15;66(2):803-11. doi: 10.1158/0008-5472.CAN-05-1972. Cancer Res. 2006. PMID: 16424012
-
Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.Br J Cancer. 2001 Mar 23;84(6):768-75. doi: 10.1054/bjoc.2000.1652. Br J Cancer. 2001. PMID: 11259090 Free PMC article.
-
Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.Int J Cancer. 2005 Sep 1;116(3):385-94. doi: 10.1002/ijc.21010. Int J Cancer. 2005. PMID: 15818598
-
EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.Adv Exp Med Biol. 2006;587:41-52. doi: 10.1007/978-1-4020-5133-3_4. Adv Exp Med Biol. 2006. PMID: 17163154 Review.
-
Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.Clin Cancer Res. 2010 Aug 15;16(16):4077-83. doi: 10.1158/1078-0432.CCR-09-2261. Epub 2010 Jun 14. Clin Cancer Res. 2010. PMID: 20547696 Free PMC article. Review.
Cited by
-
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.Biochem Biophys Res Commun. 2010 Nov 5;402(1):129-34. doi: 10.1016/j.bbrc.2010.09.129. Epub 2010 Oct 8. Biochem Biophys Res Commun. 2010. PMID: 20933505 Free PMC article.
-
The fascinating world of RNA interference.Int J Biol Sci. 2009;5(2):97-117. doi: 10.7150/ijbs.5.97. Epub 2009 Jan 15. Int J Biol Sci. 2009. PMID: 19173032 Free PMC article. Review.
-
Endogenous EWSR1-FLI1 degron alleles enable control of fusion oncoprotein expression in tumor cell lines and xenografts.bioRxiv [Preprint]. 2024 Oct 29:2024.10.27.620498. doi: 10.1101/2024.10.27.620498. bioRxiv. 2024. PMID: 39554175 Free PMC article. Preprint.
-
Challenges in modeling EWS-FLI1-driven transgenic mouse model for Ewing sarcoma.Am J Transl Res. 2021 Nov 15;13(11):12181-12194. eCollection 2021. Am J Transl Res. 2021. PMID: 34956445 Free PMC article. Review.
-
Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma.Mol Cancer. 2024 Oct 5;23(1):222. doi: 10.1186/s12943-024-02115-7. Mol Cancer. 2024. PMID: 39367409 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
